The FDA Just Voted on Peptides. Here’s What the Vote Actually Means
The longevity industry is moving fast. On July 23–24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) voted to recommend six peptides — BPC-157, KPV, TB-500, MOTS-c, epitalon, and Semax — for addition to the 503A Bulk Drug Substances list, the roster of ingredients licensed compounding pharmacies may legally prepare against a prescription. A […]
The FDA Just Voted on Peptides. Here’s What the Vote Actually Means Read More »